Article3D printing in medicine2026
Enhancing bioactivity of 3D-printed porous scaffolds with self-assembling peptide hydrogels for cartilage tissue engineering.
Article in 3D printing in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCartilage repair is challenging due to the tissue's limited regenerative capacity. Synthetic 3D-printed scaffolds provide essential structural support, but typically lack the bioactivity needed for cell integration. A promising approach combines 3D-printed porous scaffolds filled with self-assembling peptide hydrogels, which serve as nanofiber scaffolds inside the macropores of the structural scaffold, creating a hybrid structure.
methodsThe selection strategy for the 3D printing of the synthetic scaffolds was driven by two distinct cross-linking processes: a vinyl-ester based thiol-ene photopolymer crosslinked via free radical polymerization and printed with digital light processing, resulting in a stiff mechanical network and polydimethylsiloxane, namely AMSil™ 20503-50 from the AMSil™ 20,503 series, printed via liquid deposition modeling and crosslinked through polyaddition, which yields flexible scaffolds capable of adapting to dynamic mechanical environments. These properties make them suitable for load-bearing applications where structural integrity is paramount. Both 3D-printed scaffold types, characterized by interconnected macropores ranging from 0.8 to 1.2 mm, were augmented with a peptide hydrogel scaffold, such as RADA16 and IEIK13, that self-assembles inside the macropores to create a nanofiber network mimicking the extracellular matrix and enhancing bioactivity.
resultsThe hybrid structure, combining the macropores of a structural 3D-printed scaffold and the nanofiber network of the peptide hydrogel scaffold improved cell adhesion, proliferation, and differentiation. Comparative analysis showed that, while both RADA16 and IEIK13 hydrogels enhanced cell integration within the macropores, RADA16 was especially effective in supporting cartilage-like ECM formation.
conclusionsThe creation of a hybrid scaffold with hierarchical porosity-integrating the structural macropores of a synthetic 3D-printed scaffold with the bioactive nanofiber network of a peptide hydrogel-addresses the limitations of purely structural scaffolds. The hybrid approach not only enhances fast and accessible scaffold fabrication but also accelerates the development of functional scaffolds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.